We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synpromics Collaborate with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease

News   Nov 28, 2017 | Original story from Synpromics

 
Synpromics Collaborate with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease
 
 
 

RELATED ARTICLES

Keeping Score On Polygenic Risk Factors

News

A new study reports a new kind of genome analysis that could identify large fractions of the population who have a much higher risk of developing serious common diseases, including coronary artery disease, breast cancer, or type 2 diabetes.

READ MORE

Medicine of the Future Against Infection and Inflammation?

News

Researchers have mapped how the body's own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.

READ MORE

Worm Study Shows How Genes Drive Aging

News

Ageing in worms mainly results from the direct action of genes and not from random wear and tear or loss of function, and the same is likely to be true in humans, according to research by UCL, Lancaster University and Queen Mary University of London scientists.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE